Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesis

Cellular and Molecular Life Sciences

Volumn 67, Issue 23, 2010, Pages 4095-4106

  Fricke, Stephan ^a,b   Fricke, Christian ^d   Oelkrug, Christopher ^a   Hilger, Nadja ^a   Schönfelder, Uta ^c   Kamprad, Manja ^a,b   Lehmann, Jörg ^a   Boltze, Johannes ^a,b   Emmrich, Frank ^a,b   Sack, Ulrich ^a,b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Evangelic Diaconic Hospital   (Germany)

^d Klinik Allerheiligenberg   (Switzerland)

Author keywords

NA BMCs; Real time PCR; Stem cells; Transgenic mice; Transplantation

Indexed keywords

ATAXIN 1; CD11B ANTIGEN; OSTEOCALCIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL POPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROID CELL; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; HEMATOPOIESIS; IN VIVO STUDY; LYMPHOID CELL; MESENCHYME CELL; MONOCYTE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL;

ANIMALS; ANTIGENS, CD4; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELLS, CULTURED; HEMATOPOIESIS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

MURINAE; MUS; MUS MUSCULUS;

EID: 78651269362     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0427-2     Document Type: Article

References (48)

1. Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, Miao DS (2009) Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration. Bone Marrow Transplant 43:69-81
2. Fricke S, Ackermann M, Stolzing A, Schimmelpfennig C, Hilger N, Jahns J, Hildebrandt G, Emmrich F, Ruschpler P, Pösel C, Kamprad M, Sack U (2009) Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment. PLoS One 4: e6157
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-491
4. Zhang ZX, Wang RZ, Li GL, Dou WC, Li SF, Wei JJ, Wei YK, Zhao FF, Kong YG, Wu HT, Fan M (2006) Study on transdifferentiation of adult human myoblasts into neural precursor cells and its implantation in rats. Zhonghua Yi Xue Za Zhi 86:2756-2760
5. Clarke E, McCann SR (1991) Stromal colonies can be grown from the non-adherent cells in human long-term bone marrow cultures. Eur J Haematol 46:296-300
6. Scutt A, Zeschnigk M, Bertram P (1995) PGE2 induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism. Prostaglandins 49:383-395
7. Ferrari G, Cusella-De AG, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1998) Muscle regeneration by bone marrowderived myogenic progenitors. Science 279:1528-1530
8. Wlodarski KH, Galus R, Wlodarski P (2004) Non-adherent bone marrow cells are a rich source of cells forming bone in vivo. Folia Biol (Praha) 50:167-173
9. Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F (2000) A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses. J Immunol Methods 246:37-50
10. Laub R, Dorsch M, Wenk K, Emmrich F (2001) Induction of immunologic tolerance to tetanus toxoid by anti-human CD4 in HLA-DR3 (+)/human CD4 (+)/murine CD4 (-) multiple transgenic mice. Transplant Proc 33:2182-2183
11. Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G (2001) CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma 42:1195-1206
12. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG, Maio M (2001) Endoglin: an accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 188:1-7
13. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984-992
14. Kawai K, Tsuno NH, Matsuhashi M, Kitayama J, Osada T, Yamada J, Tsuchiya T, Yoneyama S, Watanabe T, Takahashi K, Nagawa H (2005) CD11b-mediated migratory property of peripheral blood B cells. J Allergy Clin Immunol 116:192-197
15. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S (1991) Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 174:63-71
16. Mizrak D, Brittan M, Alison MR (2008) CD133: molecule of the moment. J Pathol 214:3-9
17. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012
18. Otero DC, Anzelon AN, Rickert RC (2003) CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 170:73-83
19. Lange C, Li Z, Fang L, Baum C, Fehse B (2007) CD34 modulates the trafficking behavior of hematopoietic cells in vivo. Stem Cells Dev 16:297-304
20. Nielsen JS, McNagny KM (2009) CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16:487-496
21. Gangenahalli GU, Singh VK, Verma YK, Gupta P, Sharma RK, Chandra R, Luthra PM (2006) Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev 15:305-313
22. Earl LA, Baum LG (2008) CD45 glycosylation controls T-cell life and death. Immunol Cell Biol 86:608-615
23. Wiesmann A, Buhring HJ, Mentrup C, Wiesmann HP (2006) Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head Face Med 2:8
24. Mehta K, Shahid U, Malavasi F (1996) Human CD38, a cell-surface protein with multiple functions. FASEB J 10:1408-1417
25. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 282:11849-11857
26. Balazs AB, Fabian AJ, Esmon CT, Mulligan RC (2006) Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 107:2317-2321
27. Tang XB, Liu DP, Liang CC (2001) Regulation of the transcription factor GATA-1 at the gene and protein level. Cell Mol Life Sci 58:2008-2017
28. Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, Leiden JM (1991) Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J 10:1187-1192
29. Pan G, Thomson JA (2007) Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17:42-49
30. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcindeficient mice. Nature 382:448-452
31. Ito M, Anan K, Misawa M, Kai S, Hara H (1996) In vitro differentiation of murine Sca-1+Lin-cells into myeloid, B cell and T cell lineages. Stem Cells 14:412-418
32. Bradfute SB, Graubert TA, Goodell MA (2005) Roles of Sca-1 in hematopoietic stem/progenitor cell function. Exp Hematol 33:836-843
33. Laub R, Dorsch M, Wedekind D, Meyer D, Schroder S, Ermann J, Lehmann J, Mahler M, Emmrich F, Hedrich HJ (1999) Replacement of murine by human CD4 and introduction of HLADR17 in mice: a triple-transgenic animal model to study human MHC II-CD4 interaction in situ. J Exp Anim Sci 39:122-135
34. Dobson KR, Reading L, Haberey M, Marine X, Scutt A (1999) Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65:411-413
35. Tschetter JR, Mozes E, Shearer GM (2000) Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol 165:5987-5994
36. Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J Jr, Ferrara JL (1998) Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 102:1882-1891
37. + regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Stem Cells Dev. doi:10.1089/scd.2005.14. 310
38. Orasch C, Weisser M, Mertz D, Conen A, Heim D, Christen S, Gratwohl A, Battegay, M, Widmer A, Fluckiger U (2009) Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. doi:10.1038/bmt.2009.187
39. Fuhrer M, Claviez A, Klein B, Humpe A, Schrauder A (2009) Re-transplantation from the same unrelated donor in three adolescents with severe aplastic anemia after graft rejection. Klin Padiatr 221:358-361
40. Gratwohl A, Baldomero H (2009) Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 16:420-426
41. Tian Y, Deng YB, Huang YJ, Wang y (2008) Bone marrowderived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Immunol Invest 37:29-42
42. Kuhn NZ, Tuan RS (2009) Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 222:268-277
43. Le BK, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579-1586
44. Hansen W, Westendorf AM, Buer J (2008) Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation. Inflamm Allergy Drug Targets 7:217-223
45. + regulatory T cells in hematopoietic stem cell transplantation. Curr Top Microbiol Immunol 293:265-285
46. Blache C, Chauvin JM, Marie-Cardine A, Contentin N, Pommier P, Dedreux I, Francois S, Jacquot S, Bastit D, Boyer O (2009) Reduced frequency of regulatory T cells in peripheral blood stem cell as compared to bone marrow transplants. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2009.10.027
47. + regulatory T cells approach the clinic. Cytotherapy 10:655-656
48. Chroma Werksschrift (1962) Ausgewählte Färbemethoden für Botanik, Parasitologie, Zoologie, Chroma-Ges. Schmid, Stuttgart- Untertürkheim